Plaque Reversal With Early, Aggressive Lipid Lowering Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Plaque Reversal With Early, Aggressive Lipid Lowering Therapy — Stella

Recruiting

Back to Coronary Artery Disease Progression trials

Trial locations(1 site)

Netherlands

Amsterdam UMC, location AMC, Amsterdam, North Holland

Key details

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment target

~60 participants

Started

July 2022

Primary completion

December 2026

Age range

18 Years – 50 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov